Study of Drug Resistance in Chemotherapy Induced by Extracellular Vesicles on a Microchip
Drug resistance in chemotherapy has been greatly challenging for cancer treatment. Research has revealed that extracellular vesicles (EVs) secreted by drug-resistant cells could induce chemoresistance in susceptible cells. However, there are few ways to give direct evidence of it. Herein, we have proposed a microchip-based system to study the drug resistance of a wild-type human lung adenocarcinoma cell line (A549/WT) induced by EVs derived from A549/DDP cells that are resistant to cisplatin (DDP) inherently. EVs derived from A549/DDP were proved to be the crucial factor that enhanced the resistance of A549/WT to DDP through live and dead cell staining, cell viability testing, and immunofluorescence of P-glycoprotein in the off-chip assay. Then, it was further validated that drug resistance of A549/WT cells to DDP significantly increased after being cocultured with A549/DDP cells within 96 h in the on-chip assay. These findings proved that the change of A549/WT drug resistance was caused by intercellular interaction, which was mainly mediated by EVs. In addition, we successfully reversed the EV-induced drug resistance of A549/WT cells by combining DDP and metformin, a hypoglycemic drug with low cytotoxicity when used alone. This microchip system provides a novel tool that has great potential for the investigation of cell interaction, drug resistance, and the tumor microenvironment in fundamental and clinical medicine.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:94 |
---|---|
Enthalten in: |
Analytical chemistry - 94(2022), 48 vom: 06. Dez., Seite 16919-16926 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Fang, Tianyuan [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antineoplastic Agents |
---|
Anmerkungen: |
Date Completed 07.12.2022 Date Revised 20.12.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1021/acs.analchem.2c04330 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM349338329 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM349338329 | ||
003 | DE-627 | ||
005 | 20231226042359.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1021/acs.analchem.2c04330 |2 doi | |
028 | 5 | 2 | |a pubmed24n1164.xml |
035 | |a (DE-627)NLM349338329 | ||
035 | |a (NLM)36420757 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Fang, Tianyuan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Study of Drug Resistance in Chemotherapy Induced by Extracellular Vesicles on a Microchip |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.12.2022 | ||
500 | |a Date Revised 20.12.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Drug resistance in chemotherapy has been greatly challenging for cancer treatment. Research has revealed that extracellular vesicles (EVs) secreted by drug-resistant cells could induce chemoresistance in susceptible cells. However, there are few ways to give direct evidence of it. Herein, we have proposed a microchip-based system to study the drug resistance of a wild-type human lung adenocarcinoma cell line (A549/WT) induced by EVs derived from A549/DDP cells that are resistant to cisplatin (DDP) inherently. EVs derived from A549/DDP were proved to be the crucial factor that enhanced the resistance of A549/WT to DDP through live and dead cell staining, cell viability testing, and immunofluorescence of P-glycoprotein in the off-chip assay. Then, it was further validated that drug resistance of A549/WT cells to DDP significantly increased after being cocultured with A549/DDP cells within 96 h in the on-chip assay. These findings proved that the change of A549/WT drug resistance was caused by intercellular interaction, which was mainly mediated by EVs. In addition, we successfully reversed the EV-induced drug resistance of A549/WT cells by combining DDP and metformin, a hypoglycemic drug with low cytotoxicity when used alone. This microchip system provides a novel tool that has great potential for the investigation of cell interaction, drug resistance, and the tumor microenvironment in fundamental and clinical medicine | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Antineoplastic Agents |2 NLM | |
650 | 7 | |a Cisplatin |2 NLM | |
650 | 7 | |a Q20Q21Q62J |2 NLM | |
700 | 1 | |a Lu, Wei |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Jingfeng |e verfasserin |4 aut | |
700 | 1 | |a Ge, Ke |e verfasserin |4 aut | |
700 | 1 | |a Chen, Zhanhong |e verfasserin |4 aut | |
700 | 1 | |a Wang, Min |e verfasserin |4 aut | |
700 | 1 | |a Yao, Bo |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Analytical chemistry |d 1965 |g 94(2022), 48 vom: 06. Dez., Seite 16919-16926 |w (DE-627)NLM000025771 |x 1520-6882 |7 nnns |
773 | 1 | 8 | |g volume:94 |g year:2022 |g number:48 |g day:06 |g month:12 |g pages:16919-16926 |
856 | 4 | 0 | |u http://dx.doi.org/10.1021/acs.analchem.2c04330 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 94 |j 2022 |e 48 |b 06 |c 12 |h 16919-16926 |